Cargando…

Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis

INTRODUCTION: The aim of this study was to compare healthcare resource utilization (HCRU) before and after initiation of eslicarbazepine acetate (ESL) in the long-term care (LTC) setting (rehabilitation center, mental health center, LTC non-skilled nursing facility/assisted-living facility, home hea...

Descripción completa

Detalles Bibliográficos
Autores principales: Mehta, Darshan, Shah, Drishti, Desai, Vibha, DeKoven, Mitch, DePue, Ronald, Williams, G. Rhys, Saffel, Dana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571427/
https://www.ncbi.nlm.nih.gov/pubmed/33826104
http://dx.doi.org/10.1007/s40120-021-00244-5
_version_ 1784595019542298624
author Mehta, Darshan
Shah, Drishti
Desai, Vibha
DeKoven, Mitch
DePue, Ronald
Williams, G. Rhys
Saffel, Dana
author_facet Mehta, Darshan
Shah, Drishti
Desai, Vibha
DeKoven, Mitch
DePue, Ronald
Williams, G. Rhys
Saffel, Dana
author_sort Mehta, Darshan
collection PubMed
description INTRODUCTION: The aim of this study was to compare healthcare resource utilization (HCRU) before and after initiation of eslicarbazepine acetate (ESL) in the long-term care (LTC) setting (rehabilitation center, mental health center, LTC non-skilled nursing facility/assisted-living facility, home health, assisted living, nursing home, other/unknown). METHODS: This retrospective analysis used IQVIA’s New Data Warehouse, which includes deterministically linked LTC, prescription, and professional fee claims data and IQVIA Hospital Charge Data Master database. The study period was 1 April 2013 to 31 December 2019. The index date was the date of ESL initiation in the LTC setting. Inclusion criteria were: (1) ≥ 1 new ESL prescription between 1 April 2014 and 31 December 2018; (2) diagnosis of focal seizure (FS) during the 12 months pre-index date; and (3) no ESL prescription during the 12-month period pre-index. A 12-month pre-post analysis compared epilepsy-specific and all-cause HCRU before and after ESL initiation. Categorical variables were compared with McNemar’s tests. RESULTS: A total of 307 patients (mean age 52.2 years, 57.7% male) with FS were included, of whom 24.8% were in nursing homes. Patients used a mean of 3.1 antiseizure drugs prior to initiation of ESL, and 87.9% of patients initiated ESL as adjunctive treatment. There were significant reductions in proportion of patients with epilepsy specific physician office visits, emergency department (ED) visits, hospitalizations, and all-cause physician office visits and hospitalizations in the post-index period compared to the pre-index period (P < 0.05). Similar results were observed in sensitivity (patients with an epilepsy diagnosis) and subgroup analyses [presence or absence of intellectual developmental disorders or age (≥ 65 and < 65 years)]. CONCLUSION: Proportion of patients with epilepsy-specific physician office visits, ED visits, hospitalizations, and all-cause physician office visits and hospitalizations were significantly reduced following initiation of ESL in patients with FS in LTC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40120-021-00244-5.
format Online
Article
Text
id pubmed-8571427
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-85714272021-11-15 Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis Mehta, Darshan Shah, Drishti Desai, Vibha DeKoven, Mitch DePue, Ronald Williams, G. Rhys Saffel, Dana Neurol Ther Original Research INTRODUCTION: The aim of this study was to compare healthcare resource utilization (HCRU) before and after initiation of eslicarbazepine acetate (ESL) in the long-term care (LTC) setting (rehabilitation center, mental health center, LTC non-skilled nursing facility/assisted-living facility, home health, assisted living, nursing home, other/unknown). METHODS: This retrospective analysis used IQVIA’s New Data Warehouse, which includes deterministically linked LTC, prescription, and professional fee claims data and IQVIA Hospital Charge Data Master database. The study period was 1 April 2013 to 31 December 2019. The index date was the date of ESL initiation in the LTC setting. Inclusion criteria were: (1) ≥ 1 new ESL prescription between 1 April 2014 and 31 December 2018; (2) diagnosis of focal seizure (FS) during the 12 months pre-index date; and (3) no ESL prescription during the 12-month period pre-index. A 12-month pre-post analysis compared epilepsy-specific and all-cause HCRU before and after ESL initiation. Categorical variables were compared with McNemar’s tests. RESULTS: A total of 307 patients (mean age 52.2 years, 57.7% male) with FS were included, of whom 24.8% were in nursing homes. Patients used a mean of 3.1 antiseizure drugs prior to initiation of ESL, and 87.9% of patients initiated ESL as adjunctive treatment. There were significant reductions in proportion of patients with epilepsy specific physician office visits, emergency department (ED) visits, hospitalizations, and all-cause physician office visits and hospitalizations in the post-index period compared to the pre-index period (P < 0.05). Similar results were observed in sensitivity (patients with an epilepsy diagnosis) and subgroup analyses [presence or absence of intellectual developmental disorders or age (≥ 65 and < 65 years)]. CONCLUSION: Proportion of patients with epilepsy-specific physician office visits, ED visits, hospitalizations, and all-cause physician office visits and hospitalizations were significantly reduced following initiation of ESL in patients with FS in LTC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s40120-021-00244-5. Springer Healthcare 2021-04-07 /pmc/articles/PMC8571427/ /pubmed/33826104 http://dx.doi.org/10.1007/s40120-021-00244-5 Text en © The Author(s) 2021, corrected publication 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Research
Mehta, Darshan
Shah, Drishti
Desai, Vibha
DeKoven, Mitch
DePue, Ronald
Williams, G. Rhys
Saffel, Dana
Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis
title Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis
title_full Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis
title_fullStr Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis
title_full_unstemmed Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis
title_short Healthcare Resource Utilization Among Patients with Focal Seizures Treated with Eslicarbazepine Acetate in the US Long-Term Care Setting: A Retrospective Claims Database Analysis
title_sort healthcare resource utilization among patients with focal seizures treated with eslicarbazepine acetate in the us long-term care setting: a retrospective claims database analysis
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8571427/
https://www.ncbi.nlm.nih.gov/pubmed/33826104
http://dx.doi.org/10.1007/s40120-021-00244-5
work_keys_str_mv AT mehtadarshan healthcareresourceutilizationamongpatientswithfocalseizurestreatedwitheslicarbazepineacetateintheuslongtermcaresettingaretrospectiveclaimsdatabaseanalysis
AT shahdrishti healthcareresourceutilizationamongpatientswithfocalseizurestreatedwitheslicarbazepineacetateintheuslongtermcaresettingaretrospectiveclaimsdatabaseanalysis
AT desaivibha healthcareresourceutilizationamongpatientswithfocalseizurestreatedwitheslicarbazepineacetateintheuslongtermcaresettingaretrospectiveclaimsdatabaseanalysis
AT dekovenmitch healthcareresourceutilizationamongpatientswithfocalseizurestreatedwitheslicarbazepineacetateintheuslongtermcaresettingaretrospectiveclaimsdatabaseanalysis
AT depueronald healthcareresourceutilizationamongpatientswithfocalseizurestreatedwitheslicarbazepineacetateintheuslongtermcaresettingaretrospectiveclaimsdatabaseanalysis
AT williamsgrhys healthcareresourceutilizationamongpatientswithfocalseizurestreatedwitheslicarbazepineacetateintheuslongtermcaresettingaretrospectiveclaimsdatabaseanalysis
AT saffeldana healthcareresourceutilizationamongpatientswithfocalseizurestreatedwitheslicarbazepineacetateintheuslongtermcaresettingaretrospectiveclaimsdatabaseanalysis